MentionFox
Home › funding signals › CND Life Sciences, Inc.
Company · SEC filings

CND Life Sciences, Inc. funding history

CND Life Sciences, Inc. has 8 Form D filings on record, from 2023-03-24 to 2026-08-03. Together its new offerings report $4.31M sold.

Funding historyFounders and team

What do you want to do with CND Life Sciences, Inc.?

Based
SCOTTSDALE, ARIZONA
Industry group
Biotechnology
Filings
8
Raised (new offerings)
$4.31M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-08-03Amendment
first sale 2026-06-09
$6.32M$6.32MSEC filing
2026-06-16New offering
first sale 2026-06-09
$4.31M$6.25MSEC filing
2025-05-06Amendment——SEC filing
2025-04-15Amendment——SEC filing
2025-03-06Filing——SEC filing
2024-03-27Filing——SEC filing
2023-07-24Filing——SEC filing
2023-03-24Amendment——SEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from CND Life Sciences, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/cnd-life-sciences-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
CND Life Sciences, Inc. funding history: 8 SEC filings, $4.31M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/cnd-life-sciences-inc